![](/img/cover-not-exists.png)
An internally validated new clinical and inflammation-based prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib
Diaz-Beveridge, R., Bruixola, G., Lorente, D., Caballero, J., Rodrigo, E., Segura, Á., Akhoundova, D., Giménez, A., Aparicio, J.Language:
english
Journal:
Clinical and Translational Oncology
DOI:
10.1007/s12094-017-1720-4
Date:
August, 2017
File:
PDF, 495 KB
english, 2017